Clinical trial
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia…
NCT00003384 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003384 |
|---|---|
| Title | Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer |
| Official title | Expression of the MN Protein in Atypical Glandular Cells of Undetermined Significance (Agus or Agcus) As a Potential Diagnostic Biomarker of Cervical Dysplasia/Neoplasia |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Precancerous Condition, Stage 0 Cervical Cancer |
| Intervention type | Other, Procedure |
| Interventions | Cervical Papanicolaou Test, Conization, Laboratory Biomarker Analysis |
| Enrollment | 684 |
| Start date | Sep 1, 1998 |
| Primary completion | Jan 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | May 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: